During an MM&M webcast, Pfizer's Bob Kristofco, MSW, said pharma "continues to have an expectation for more outcomes-oriented CME," and that he expects grants from public and private sources will "begin to assess the current climate for [CPD]."
During an MM&M webcast, Pfizer’s Bob Kristofco, MSW,said pharma “continues to have an expectation for more outcomes-oriented CME,”and that he expects grants from public and private sources will “begin toassess the current climate for [CPD].”
From the January 01, 2008 Issue of MM+M - Medical Marketing and Media
Get the most out of 
Register for free and enjoy unlimited access to:
